3D Cell Culture Market Size Worth USD 3.94 Billion by 2030| MRFR

Recent market research completed by Market Research Future (MRFR) on the 3D cell culture market was comprehensive and obtained valuable statistical data on the market’s progress and opportunities during the forecast period of 2020 to 2027. The report presents an overall market overview, with references to the market size, pricing trends, market CAGR, industry outlook, market segmentations, geographical coverage, market forecast, and even companies profiled. The following details from the report's analysis have provided key insight into the 3D cell culture market, as well as a more comprehensive overview of the opportunities it presents.

Market Overview

The 3D Cell Culture Market is expected to reach USD 3.94 Billion by 2030 at 14.90% CAGR during the forecast period 2022-2030.This rise is related to a greater understanding of the advantages of 3D cell culture in the fields of drug discovery and cellular research. During the study period, the shrinking of organs on chips and the rise in government and corporate investments are among the most important factors driving the market for 3D cell culture.

The growing cases of cancer, microbial infections and related demand for a suitable therapeutic space helps pique the 3D cell culture market's interests. 3D cell cultures have the potential to rapidly identify novel drugs and to have an in-depth understanding of the cell's behavior and physiology, prompting for an augmentation in the market revenue.

Additionally, the growing focus of companies to drive novel applications and bio-chips on a 3D model are helping the market witness growth. Bio-chip cell culture systems offer an opportunity to investigate metabolic processes in a microenvironment and help reduce the need for animal testing. This in turn, helps boost the market’s revenues.

Also, the various advantages offered by modern 3D cell culture technologies, such as improved cell-cell interactions, scaffold-mediated cell-matrix interactions, safer blood supply and more physiological media conditions, are aiding in the market's growth.

However, the high cost related to 3D cell culture technologies and the lack of robotic technologies may hamper the market's growth during the review period.

Key Players

Some of the players identified across the value chain of 3D cell culture market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Corning Incorporated (US), Becton Dickinson and Co (US), InSphero AG (Switzerland), Lonza Group (Switzerland), Global cell Solutions Inc. (US), Nano3D Biosciences Inc. (US), 3D Biomatrices (US), and NanoBioMatters Industries, S.L. (Spain).

Market Segmentation

The market of 3D cell culture has been studied for the following segments - product & service, application, end user, and region.

Based on product & service, consumable, instruments, services, and software & services are the segments. Among these, the consumables category holds the largest market share and is anticipated to be the market leader throughout the analysis period. This is because of their wide utility in research laboratories. Also, these are available in various forms such as photosensitive formats, cell-ready assays, nano-composites, hydrogels and ECM matrices that offer accurate results.

Based on application, the 3D cell culture market includes vaccine & therapeutics development, cancer research, drug discovery, stem cell research, tissue engineering, tissue chip development, and clinical research. Among them, the vaccine & therapeutics development sector holds the biggest market share and is anticipated to lead the market through 2027.

Based on end user, the segments include contract research organizations, government research institutions & universities, biotechnology & pharmaceutical companies, and research institutes.

Based on regions, the market caters to North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW).

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of 3D Cell Culture Market Research Report

Regional Analysis

The study contains an market analysis of the 3D cell culture in North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW).

In the approaching years, North America is anticipated to hold a significant portion of the 3D cell culture market. The significant market share is primarily attributable to the increasing quantity of studies on certain diseases. In addition, the presence of some of the industry's most prominent companies has assisted in establishing a solid foothold in the region.

During the time under consideration, Europe is anticipated to have significant growth. In the region, major financing has been attracted by the need to advance in the field of drug discovery and the presence of numerous government initiatives.
The Asia-Pacific region is projected to see the highest CAGR over the time under review. This is attributable to the increase in government funding, the expansion of the healthcare industry, and the growing awareness of 3D cell culture services. Additionally, the rising number of positions for research and bioscience scientists can contribute to the expansion of the area market.

Recent Developments

• As per MRFR, in April 2020, Nano3D Biosciences announced ’Cell-Chips and proprietary assay kits for high-throughput special optimization and drug discovery workflow’.

• In October 2019, Corning Incorporated announced the launch of yet another 3D cell culture product called ’Falcon AQUALON ENGINE’. This is a new cell culture platform that offers an integrated environment to facilitate the understanding of various cellular models.

• In April 2019, Lonza Group AG announced the launch of ’ZellMenter Research Scale System’ in order to improve the control of 3D bioprinting applications.

• In May 2019, 3D Biomatrices announced the launch of ’CUBIC Device’ for stemming the cell culture and cell research solutions.

Market Outlook

The 3D cell culture market is projected to reach a market size of USD 2.76 billion, showcasing a CAGR of 13.7% during the forecast period. The rising urge to reduce animal testing in order to perform various drug analyses is fueling the market growth. Also, the increasing use of 3D cell culture systems to understand in-depth of cellular physiologies and interactions with biological systems is showing encouraging signs of growth. What’s more, the application of 3D cell culture in the realm of vaccination, tissue engineering, and personalized medicine has been increasing, prompting the market’s interest.

The presence of some of the major leaders of the market, strategic developments and collaborations with government entities has influenced the growth graph of the global market.

In addition, the increasing number of initiatives and funds from government, corporate organizations, and academic institutions have further attributed to the market growth of 3D cell culture. For example, the National Institute of Health Support (NHS) in the UK has funded several research projects that involve the use of 3D cell cultures.

Overall, the growing inclination towards 3D cell cultures due to its potential applications and the prominent role played by both private and public players have bolstered the market of 3D cell culture. Such factors make the market highly promising for the review period.